Cutaneous response to recombinant interleukin 2 in human immunodeficiency virus 1-seropositive individuals.

We report that 11 human immunodeficiency virus 1 (HIV-1)-seropositive patients, including three AIDS patients, were able to generate a cellular immune response to the intradermal injection of low doses (2-10 micrograms) of recombinant interleukin 2 (rIL-2). A dose-dependent zone of induration appear...

Full description

Saved in:
Bibliographic Details
Main Authors: McElrath, M J, Kaplan, G, Burkhardt, R A, Cohn, Z A
Format: Artigo
Language:Inglês
Published: 1990
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC54412/
https://ncbi.nlm.nih.gov/pubmed/2143021
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items